A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer

Liu, Zhixian, Li, Mengyuan, Jiang, Zehang, Wang, Xiaosheng·2018·Translational Oncology
DOI 10.1016/j.tranon.2018.01.011

Cited by (279)

Items 201–279 of 279

  1. Deconvolution of cancer cell states by the XDec-SM method
    Oscar D. Murillo, Varduhi Petrosyan, Emily L. LaPlante, Lacey Elizabeth Dobrolecki, Michael T. Lewis, Aleksandar Milosavljevic · 2023 · PLoS Computational Biology
  2. Dysregulated Forkhead Box (FOX) Genes Association with Survival Prognosis, Anti-tumor Immunity, and Key Targeting Drugs in Colon Adenocarcinoma
    Qian Reuben Xie, Jie Wang, Xingchen Peng · 2023 · Archives of Iranian Medicine
  3. Tackling suppressive cancer microenvironment by NARF-derived immune modulatory vaccine and its validation using simulation strategies
    Priyanga Paranthaman, Shanthi Veerappapillai · 2024 · Frontiers in Physics
  4. Thematic trends and knowledge-map of tumor-infiltrating lymphocytes in breast cancer: a scientometric analysis
    Jinan Shi, Lei Pan, Feixia Ma, Ganlu Zhang, Yin Duan · 2024 · Frontiers in Oncology
  5. Correlation analysis of DLG5 and PD-L1 expression in triple-negative breast cancer
    Jingmin Che, Bo Chen, Xusheng Wang, Baoe Liu, Cuixiang Xu, Huxia Wang, Jingying Sun, Qing Feng, Xiangrong Zhao, Zhangjun Song · 2025 · BMC Cancer
  6. Explore Genomic Profiles for Triple-Negative Breast Cancer to Discover Drug Targets
    Xiaosheng Wang · 2018 · Elsevier eBooks
  7. Molecular profiling in HNSCC patients targets potential responsiveness to ICIs
    Andrea Sacconi, Paola C. Muti, Claudio Pulito, Raul Pellini, Sabrina Strano, Paolo Bossi, Giovanni Blandino · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Understanding the role of neighborhood deprivation in racial disparities in triple‐negative breast cancer
    Lauren E. Barber, Maret L. Maliniak, Jasmine M. Miller‐Kleinhenz, Leah Moubadder, Demetria Joy Smith-Graziani, Jeffrey M. Switchenko, Kevin C. Ward, Lauren E. McCullough · 2025 · Cancer
  9. Immunogenomic diversity of triple-negative breast cancers in obese and non-obese black and white women
    Fokhrul M. Hossain, Denise Danos, Jovanny Zabaleta, Xiao‐Cheng Wu, Luis Del Valle, Chindo Hicks, Jiande Wu, Jerneja Tomšič, Susan L. Neuhausen, Yuan Chun Ding et al. · 2025 · npj Breast Cancer
  10. Apatinib Mesylate in the Treatment of Advanced Triple-Negative Breast Cancer
    Xijia Huang, Chao Chen, Hao Zeng, Lili Wang, Mulan Chen, Jian Liu, Fan Wu, Weiwei Huang · 2026 · Oncology Research and Treatment
  11. Dissection of Immune Profiles in Microsatellite Stable and Low Microsatellite Instability Colon Adenocarcinoma by Multiomics Data Analysis
    Tao Yang, Jiali Lei, Qiushi Feng, Dandan Song, Xiaosheng Wang · 2022 · Journal of Oncology
  12. Immunotherapy for triple-negative breast cancer
    Yin He, Xiaosheng Wang · 2022 · Trends in Immunotherapy
  13. Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation
    Zihan Wang, Wenjing Cui, Long Liang, Jingge Qu, Yuqiang Pei, Danyang Li, Ying Luo, Yue Zhang, Yifan Qiu, Yongchang Sun · 2025 · BMC Cancer
  14. Identification of novel biomarkers and prognostic model for neuroblastoma using Mendelian randomization and transcriptomic analysis
    Yongcheng Fu, Nan Zhang, Jian Cheng, Xiaohan Qin, Xing Zhou, Xiaoran Du, Yuanyuan Wang, Jingyue Wang, Da Zhang · 2025 · Discover Oncology
  15. Identification of high-risk signatures and therapeutic targets through molecular characterization and immune profiling of TP53-mutant breast cancer
    Peter Jerome Ishmael V. Paulino, Mohammad Tasyriq Che Omar · 2025 · Journal of Genetic Engineering and Biotechnology
  16. An Integrative Genomics Approach for Associating Genetic Susceptibility with the Tumor Immune Microenvironment in Triple Negative Breast Cancer
    Chindo Hicks · 2019 · Biomedical Journal of Scientific & Technical Research
  17. Immunity and cancer: role of tumor-infiltrating lymphocytes in triple-negative breast cancer
    Ana Tečić Vuger, Zagreb, Croatia, Robert Šeparović, Ljubica Vazdar, Mirjana Pavlović, Petra Linarić, Sanda Šitić, Martina Šepetavc, Damir Vrbanec · 2021 · Libri Oncologici Croatian Journal of Oncology
  18. Identification of Key Claudin Genes Associated With Survival Prognosis and Diagnosis in the Colon Cancer Through Integrated Bioinformatic Analysis.
    Rana Abdullah Alghamdi, Maryam Hassan Al-Zahrani · 2021 · Research Square
  19. Copper chelation inhibits TGF- β pathways and suppresses epithelial-mesenchymal transition in cancer
    Ensieh M. Poursani, Daniele Mercatelli, Prahlad V. Raninga, Jessica Lilian Bell, Federica Saletta, Felix V Kohane, Y. Zheng, Jourdin R.C. Rouaen, Toni Rose Jue, Filip Michniewicz et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Clinico-pathological relationship between androgen receptor (AR) and tumor infiltrating lymphocytes (TILs) in triple negative breast cancer (TNBC)
    Thanaa Helal, Joaira Bakkach, Hagar Ibrahim Elghazawy, Ahmed Aref, Mohamed Kelany, Lamiaa Abdallah, Fatma Abdelbakey, Dalia Ali, Doaa Ali, Mai Hassan Ahmed et al. · 2021 · Research Square
  21. Single-cell RNA-seq data reveals TNBC tumor heterogeneity through characterizing subclone compositions and proportions
    Weida Wang, Jinyuan Xu, Shuyuan Wang, Peng Xia, Li Zhang, Lei Yu, Jie Wu, Qian Song, Bo Zhang, Chaohan Xu et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Análise do repertório de linfócitos T em pacientes com câncer: desvendando a resposta imune antitumoral em humanos
    Mariana Pereira Pinho · 2019
  23. Machine Learning Approaches for Decoding Information in RNA Interactions and DNA sequences
    이상선 · 2020 · Seoul National University Open Repository (Seoul National University)
  24. Effect of Aging-Related Genes on the Prognosis of Colon Cancer
    Yushu Liu, Jiantao Gong, Yanyi Huang, Qunguang Jiang · 2021 · Research Square
  25. Comprehensive Analysis of the Immune Microenvironment Reveals that CD52 is a Marker for Breast Cancer Treatment with Immune Checkpoint Inhibitors
    Qiang Wang, Xuxu Liu, Pengfei Wang, Dankun Luo, Wenqi Gao, Yuanyuan Sun, Biao Ma, Dongbo Xue, Hezheng Sun · 2021 · Research Square
  26. Identification of Prostate Cancer Subtypes Based on Immune Signature Scores in Bulk and Single Cell Transcriptomes
    Canping Chen, Xiaosheng Wang · 2022 · Research Square
  27. Identification of Prostate Cancer Subtypes Based on Immune Signature Scores in Bulk and Single Cell Transcriptomes
    Canping Chen, Xiaosheng Wang · 2021 · SSRN Electronic Journal
  28. Clinical Advances in the Treatment of Metastatic Triple Negative Breast Cancer
    号 符 · 2019 · Advances in Clinical Medicine
  29. Identification of immune-related therapeutically relevant biomarkers in breast cancer and breast cancer stem cells by transcription-wide analysis: a clinical prospective study
    Linbang Wang, Yuanyuan Wang, Jingkun Liu, Jiaojiao Tai, Xuedong Yin, Wei Liu · 2020
  30. Pan-Cancer Analysis of TASL: A Novel Immune Infiltration-Related Biomarker for Tumor Prognosis and Immunotherapy Response Prediction
    Huanyu Li, Xiaoyu Sun, Yanyun Zhao, Changzhu Zhang, Kai Jiang, Jie Ren, Lijuan Xing, Miao He · 2023 · Research Square
  31. TP53 mutation-associated immunosignatures impact on anti-PD-L1 treatment response in head and neck cancer patients.
    Andrea Sacconi, Paola C. Muti, Claudio Pulito, Raul Pellini, Sabrina Strano, Uri Ben‐David, Paolo Bossi, Giovanni Blandino · 2023 · Research Square
  32. Human Endogenous Retroviruses in Triple‐Negative Breast Cancer
    Tara Patricia Hurst, Timokratis Karamitros, Gkikas Magiorkinis · 2023
  33. Characterization of the immune environment in pregnancy-associated breast cancer
    Konstantinos Venetis, Elham Sajjadi, Mariia D. Ivanova, Fedro Alessandro Peccatori, Nicola Fusco, Elena Guerini‐Rocco · 2023 · Future Oncology
  34. The Application of Pembrolizumab in the Treatment of Triple Negative Breast Cancer
    波 陈 · 2024 · Advances in Clinical Medicine
  35. Additional file 2 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Mengyuan Li, Xiaosheng Wang · 2020 · Figshare
  36. Additional file 1 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Mengyuan Li, Xiaosheng Wang · 2020 · Figshare
  37. Additional file 2 of Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
    Huanyu Li, Xiaoyu Sun, Yanyun Zhao, Changzhu Zhang, Jiang, Kai, Jie Ren, Lijuan Xing, Miao He · 2023 · Figshare
  38. The Association of HIV Status with Triple-Negative Breast Cancer in South African Breast Cancer Patients
    Jacob Lee Dubner, Alfred I. Neugut, Maureen Joffe, Daniel S. O’Neil, Oluwatosin Ayeni, Carl Chen, Ines Buccimazza, Sharon Čačala, Laura W. Stopforth, Hayley A. Farrow et al. · 2024 · SSRN Electronic Journal
  39. Research Progress of Treatment Modalities and Related Drugs for Triple Negative Breast Cancer
    永权 刘 · 2024 · Advances in Clinical Medicine
  40. Molecular subtyping of skin cutaneous melanoma based on inflammatory response
    Qian Liu, Fangyu Ma, Guanxiong Zhang · 2024 · Heliyon
  41. Therapeutic Interventions for Breast Cancer: Advanced Breast Cancer
    Elena Fountzilas, Michail Ignatiadis · 2024 · Cancer immunotherapy
  42. Prognostic utility of spatial immunophenotyping in Asian breast cancer
    MOHAMAD HAZWAN FIKRI B KHAIRI, Haslina Makmur, Ju-Yi Tai, Pei-Sze Ng, Chien Wen Koh, Putri Nur Fatin Amir Rudin, Iman Yi Liao, Mahmoud Khattab, Amr Ahmed, Hon Sing Leong et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Integrative bioinformatics analysis unveils hub transcription factors and their interacting drugs in immunoglobulin A nephropathy: Implications for pathogenesis and treatments
    Yirui Wang, Yang Yu, Rexidan Zaker · 2025 · Journal of Genetic Engineering and Biotechnology
  44. Herbal Nanotechnology in Triple Negative Breast Cancer: A Comprehensive Review
    Vaishnavi Rahul Potavale, Miss. Shiba D.Shaikh, Mrudula Gore · 2025 · International Journal of Advanced Research in Science Communication and Technology
  45. Additional file 4 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Li, Mengyuan, Xiaosheng Wang · 2020 · Figshare
  46. Additional file 1 of Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
    Li, Huanyu, Sun, Xiaoyu, Yanyun Zhao, Changzhu Zhang, Jiang, Kai, Ren, Jie, Xing, Lijuan, He, Miao · 2023 · Figshare
  47. Additional file 1 of Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers
    Nicole J. Toney, Lynn M. Opdenaker, Kader Cicek, Lisa Frerichs, Christopher Ryan Kennington, Samuel Oberly, Holly Archinal, Rajasekharan Somasundaram, Jennifer Sims‐Mourtada · 2022 · Figshare
  48. Additional file 8 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Li, Mengyuan, Xiaosheng Wang · 2020 · Figshare
  49. Additional file 10 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Li, Mengyuan, Wang, Xiaosheng · 2020 · Figshare
  50. Additional file 9 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Li, Mengyuan, Wang, Xiaosheng · 2020 · Figshare
  51. Additional file 3 of Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
    Wang, Xinyi, Jinzhong Duanmu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang · 2020 · Figshare
  52. Additional file 1 of Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer
    Zhao, Peiqi, Xu, Yuanlin, Ji, Wei, Zhou, Shiyong, Li, Lanfang, Qiu, Lihua, Qian, Zhengzi, Wang, Xianhuo, Zhang, Huilai · 2021 · Figshare
  53. Additional file 3 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Li, Mengyuan, Xiaosheng Wang · 2020 · Figshare
  54. Additional file 1 of Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
    Ying Zhong, Li, Fangyuan, Zhang, Sumei, Yang, Zhenli, Xinyu Ren, Cao, Xi, Yali Xu, Guo, Dan, Zhou, Yidong, Mao, Feng et al. · 2023 · Figshare
  55. Additional file 1 of Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
    Wang, Xinyi, Jinzhong Duanmu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang · 2020 · Figshare
  56. Additional file 5 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Li, Lin, Li, Mengyuan, Xiaosheng Wang · 2020 · Figshare
  57. Additional file 6 of Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
    Wang, Xinyi, Jinzhong Duanmu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang · 2020 · Figshare
  58. Additional file 6 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Lin Li, Li, Mengyuan, Xiaosheng Wang · 2020 · Figshare
  59. Additional file 1 of Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles
    Laila Akhouayri, Paola Ostano, Maurizia Mello Grand, Ilaria Gregnanin, Francesca Crivelli, Sara Laurora, Daniele Liscia, Leone, Francesco, Santoro, Angela, Mulè, Antonino et al. · 2024 · Figshare
  60. Additional file 2 of Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
    Wang, Xinyi, Jinzhong Duanmu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang · 2020 · Figshare
  61. Additional file 1 of Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments
    Abraham, Madelyn J., Christophe Gonçalves, Paige A. McCallum, Gupta, Vrinda, Samuel E.J. Preston, Fan Huang, Hsiang Chou, Natascha Gagnon, Johnson, Nathalie A., Miller, Wilson H. et al. · 2024 · Figshare
  62. Additional file 7 of Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
    Wang, Xinyi, Jinzhong Duanmu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang · 2020 · Figshare
  63. Additional file 5 of Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
    Wang, Xinyi, Jinzhong Duanmu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang · 2020 · Figshare
  64. Additional file 4 of Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
    Wang, Xinyi, Jinzhong Duanmu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang · 2020 · Figshare
  65. Additional file 2 of Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
    Ying Zhong, Li, Fangyuan, Zhang, Sumei, Yang, Zhenli, Xinyu Ren, Cao, Xi, Yali Xu, Guo, Dan, Zhou, Yidong, Mao, Feng et al. · 2023 · Figshare
  66. Additional file 7 of Immunological classification of gliomas based on immunogenomic profiling
    Qiushi Feng, Li, Lin, Li, Mengyuan, Xiaosheng Wang · 2020 · Figshare
  67. Additional file 2 of Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
    Sacconi, Andrea, Muti, Paola, Claudio Pulito, Urbani, Giulia, Matteo Allegretti, Raul Pellini, Nikolay Hristov Mehterov, Uri Ben‐David, Sabrina Strano, Bossi, Paolo et al. · 2024 · Figshare
  68. Additional file 1 of Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
    Sacconi, Andrea, Muti, Paola, Claudio Pulito, Urbani, Giulia, Matteo Allegretti, Raul Pellini, Nikolay Hristov Mehterov, Uri Ben‐David, Sabrina Strano, Bossi, Paolo et al. · 2023 · Figshare
  69. TILseg: Automated Whole Slide-Level Spatial Scoring of Tumor-Infiltrating Lymphocytes Reveals Prognostic Patterns in Triple Negative Breast Cancer
    Lisa L. Carr, Abishek Sankaranarayanan, Khanh Ha, Meenal Rawlani, Anum S. Kazerouni, Jennifer M. Specht, Laura Carpin Kennedy, Daniel J. Reiter, Suzanne M. Dintzis, Daniel S. Hippe et al. · 2026 · medRxiv
  70. Navigating chemoresistance in triple-negative breast cancer: interplay between molecular signalling pathways and immune microenvironment
    Ezanee Azlina Mohamad Hanif, Afreena Afiqah Azman, Reena Rahayu Md Zin · 2026 · Molecular Biology Reports
  71. Rôle du récepteur LRP-1 dans la croissance tumorale et l’angiogenèse associée dans un modèle de cancer mammaire triple négatif
    Océane Campion · 2021 · theses.fr (ABES)
  72. RUNX1-deficiency drives immune-active ER + mammary tumorigenesis through activation of interferon signaling
    Sen Han, Dongxi Xiang, Xueqing Chen, Dongyi Zhao, Guyu Tracy Qin, Roderick Terry Bronson, Zhe Li · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  73. ELK4 transcriptionally represses MBNL1 expression to promote triple-negative breast cancer progression
    Chenhao Li, Xin Wang, Dongliang Shi, Meng Yang, Wenhua Yang, Liang Chen · 2026 · European journal of medical research
  74. EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer
    Mingzhan Xue, Sujitha Jeya, Reem Elasad, Sarra Mestiri, Fares Al‐Ejeh, Mariam Al-Muftah · 2026 · Cancers
  75. MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBC
    Ling‐Ming Tseng, Ka-Yi Lau, Ji-Lin Chen, Pei-Yi Chu, Chun‐Teng Huang, Wan‐Lun Wang, Yuan-Ya Chang, Jiun‐I Lai, Chun‐Yao Huang, Ming‐Shen Dai et al. · 2026 · Journal of Molecular Medicine
  76. CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling
    Qiushi Wang, Asad Ullah Khan, Chengcheng Hu, Emanuel F. Petricoin, Rebecca Morris, Sally E. Dickinson, Georg T. Wondrak, Liang Liu, Ann M. Bode, Noah I. Goldfarb et al. · 2026 · Cell Death and Disease
  77. Management of Early-stage Triple-negative Breast Cancer during Pregnancy in the Immunotherapy Era: A Case Report and Review of Treatment Considerations
    Lillian Sangha, Adriani Samuel Cherico, Vasu Bansal, Leila Robinson, Saharsh Silparshetty, Hyma Vani Polimera · 2026 · Journal of young women's breast cancer and health.
  78. Epigenetic landscape, key transcriptional regulators, and in vivo identification of human Tr1 cells
    Alma‐Martina Cepika, Laura Amaya, Colin Waichler, Mansi Narula, Michelle Mantilla, Benjamin Craig Thomas, Pauline P. Chen, Robert Arthur Freeborn, Mara Pavel-Dinu, Jason Nideffer et al. · 2026 · Science Advances
  79. Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response in Triple-Negative Breast Cancer Treated With Neoadjuvant Pembrolizumab Plus Chemotherapy
    Akihiro Fujimoto, Yuki Ichinose, Kazuo Matsuura, Emi Mikami, Wakako Inohana, Taeko Kurosawa, Ayako Nakame, Ayaka Sakakibara, Asami Nukui, Aya Asano et al. · 2026 · Clinical Breast Cancer